• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用球形结晶技术对甲苯磺丁脲进行颗粒设计。III. 用准乳液溶剂扩散法和溶剂变更法制备的甲苯磺丁脲球形附聚物的粉体学性质及溶出速率

Particle design of tolbutamide by the spherical crystallization technique. III. Micromeritic properties and dissolution rate of tolbutamide spherical agglomerates prepared by the quasi-emulsion solvent diffusion method and the solvent change method.

作者信息

Sano A, Kuriki T, Kawashima Y, Takeuchi H, Hino T, Niwa T

机构信息

Pharma Research Laboratories, Hoechst Japan Limited, Saitama, Japan.

出版信息

Chem Pharm Bull (Tokyo). 1990 Mar;38(3):733-9. doi: 10.1248/cpb.38.733.

DOI:10.1248/cpb.38.733
PMID:2347016
Abstract

With the objective of modifying the micromeritic properties of tolbutamide (i.e., to manufacture a highly functional powder form), particle design was attempted using a quasi-emulsion solvent diffusion (QESD) method, and the micromeritic properties and dissolution rate of the obtained spherical agglomerates were evaluated by comparison with agglomerates prepared by the solvent change (SC) method. For the production of tolbutamide agglomerates by the QESD method, a necessary condition was the addition of a sucrose fatty acid ester to the system as an emulsifying agent. The particle diameter of the agglomerates obtained by the QESD method depended on the size of the initially formed quasi-emulsion droplets, which in turn depended on the viscosity of the solution. In addition, the agglomerates were nearly perfectly spherical in shape. In the QESD method, the quasi-emulsion droplets crystallized instantaneously from the droplet surface inward. The resultant agglomerates were dense, had great mechanical strength and showed excellent flowability due to their perfect spherical shape. On the other hand, the agglomerates produced by the SC method were conglomerates of primary crystals, and fine, needle-like crystals formed on their surface. As a result, these agglomerates had a large specific surface area, and they therefore showed greater solubility than the agglomerates prepared by the QESD method.

摘要

为了改善甲苯磺丁脲的微粉特性(即制造一种高功能性的粉末形式),尝试采用准乳液溶剂扩散(QESD)法进行颗粒设计,并通过与溶剂变换(SC)法制备的团聚体进行比较,对所得球形团聚体的微粉特性和溶解速率进行了评估。采用QESD法制备甲苯磺丁脲团聚体时,一个必要条件是向体系中添加蔗糖脂肪酸酯作为乳化剂。通过QESD法获得的团聚体的粒径取决于最初形成的准乳液液滴的大小,而这又取决于溶液的粘度。此外,团聚体的形状近乎完美的球形。在QESD法中,准乳液液滴从液滴表面向内瞬间结晶。所得团聚体致密,具有很大的机械强度,并且由于其完美的球形而表现出优异的流动性。另一方面,通过SC法制备的团聚体是初级晶体的聚集体,并且在其表面形成细小的针状晶体。结果,这些团聚体具有较大的比表面积,因此它们比通过QESD法制备的团聚体表现出更大的溶解度。

相似文献

1
Particle design of tolbutamide by the spherical crystallization technique. III. Micromeritic properties and dissolution rate of tolbutamide spherical agglomerates prepared by the quasi-emulsion solvent diffusion method and the solvent change method.采用球形结晶技术对甲苯磺丁脲进行颗粒设计。III. 用准乳液溶剂扩散法和溶剂变更法制备的甲苯磺丁脲球形附聚物的粉体学性质及溶出速率
Chem Pharm Bull (Tokyo). 1990 Mar;38(3):733-9. doi: 10.1248/cpb.38.733.
2
Microstructures and pharmaceutical properties of ferulic acid agglomerates prepared by different spherical crystallization methods.不同球形结晶方法制备阿魏酸聚集物的微观结构和药物性能。
Int J Pharm. 2020 Jan 25;574:118914. doi: 10.1016/j.ijpharm.2019.118914. Epub 2019 Dec 4.
3
Towards a better understanding of the role of stabilizers in QESD crystallizations.为了更好地理解稳定剂在QESD结晶过程中的作用。
Pharm Res. 2022 Dec;39(12):3123-3136. doi: 10.1007/s11095-022-03212-2. Epub 2022 Mar 9.
4
Particle design of tolbutamide in the presence of soluble polymer or surfactant by the spherical crystallization technique: improvement of dissolution rate.通过球形结晶技术在可溶性聚合物或表面活性剂存在下制备甲苯磺丁脲的颗粒设计:提高溶解速率。
J Pharm Sci. 1987 Jun;76(6):471-4. doi: 10.1002/jps.2600760612.
5
Spherical agglomeration to improve dissolution and micromeritic properties of an anticancer drug, Bicalutamide.球形团聚改善抗癌药物比卡鲁胺的溶解和微粉学性质。
Drug Dev Ind Pharm. 2019 Jun;45(6):968-980. doi: 10.1080/03639045.2019.1585447. Epub 2019 Mar 7.
6
Enhancing flowability of lamivudine through quasi-emulsion solvent-diffusion (QESD) crystallization: A comprehensive study on surfactant impact, particle morphology by QbD concepts and tablet compression challenges.通过准乳液溶剂扩散(QESD)结晶提高拉米夫定的流动性:表面活性剂影响、QbD 概念下的颗粒形态以及片剂压缩挑战的综合研究。
Eur J Pharm Sci. 2024 Sep 1;200:106835. doi: 10.1016/j.ejps.2024.106835. Epub 2024 Jun 20.
7
Agglomeration of celecoxib by quasi-emulsion solvent diffusion method without stabilizer: effect of good solvent.无稳定剂准胶束溶剂扩散法聚集塞来昔布:良溶剂的影响。
Pharm Dev Technol. 2018 Dec;23(10):1037-1046. doi: 10.1080/10837450.2016.1270965. Epub 2017 Jan 12.
8
Definition of a solvent system for spherical crystallization of salbutamol sulfate by quasi-emulsion solvent diffusion (QESD) method.通过准乳液溶剂扩散(QESD)法进行硫酸沙丁胺醇球形结晶的溶剂体系定义。
J Pharm Sci. 2001 Oct;90(10):1620-7. doi: 10.1002/jps.1112.
9
Improved compressibility, flowability, dissolution and bioavailability of pioglitazone hydrochloride by emulsion solvent diffusion with additives.通过添加物的乳液溶剂扩散法提高盐酸吡格列酮的可压缩性、流动性、溶解性和生物利用度。
Pharmazie. 2012 Mar;67(3):215-23.
10
Agglomeration of Celecoxib by Quasi Emulsion Solvent Diffusion Method: Effect of Stabilizer.通过准乳液溶剂扩散法制备塞来昔布团聚体:稳定剂的影响
Adv Pharm Bull. 2016 Dec;6(4):607-616. doi: 10.15171/apb.2016.075. Epub 2016 Dec 22.

引用本文的文献

1
Towards a better understanding of the role of stabilizers in QESD crystallizations.为了更好地理解稳定剂在QESD结晶过程中的作用。
Pharm Res. 2022 Dec;39(12):3123-3136. doi: 10.1007/s11095-022-03212-2. Epub 2022 Mar 9.
2
Preparation and characterization of microparticles of piroxicam by spray drying and spray chilling methods.通过喷雾干燥和喷雾冷冻法制备吡罗昔康微粒及其表征
Res Pharm Sci. 2010 Jul;5(2):89-97.